Enhertu: Drug Therapy For Breast Cancer

Enhertu is used by healthcare professionals to treat patients with unresectable or metastatic HER2-positive breast cancer. Enhertu single-use vials come in 100 mg to administer intravenously. Fam-trastuzumab deruxtecan-nxki is a HER2-directed antibody and topoisomerase inhibitor conjugate. Fam-trastuzumab deruxtecan-nxki is an antibody-drug conjugate (ADC) composed of three components:
a humanized anti-HER2 IgG1 monoclonal antibody (mAb), covalently linked to a topoisomerase inhibitor, via

A tetrapeptide-based cleavable linker. Deruxtecan is composed of a protease-cleavable maleimide tetrapeptide linker and the topoisomerase inhibitor, DXd, which is an exatecan derivative.
Buy Enhertu in India at an affordable price and one can find this medicine with licensed generic suppliers.